The cholesterol-lowering drugs known as statins are already one of the most commonly prescribed medications, taken by 15 million Americans in an attempt to ward off heart disease. Now, a new study suggests that the drugs may also reduce the risk of Alzheimer’s and dementia by 50 percent.
While the provocative finding offers hope that the cholesterol-reducing drugs might help against Alzheimer’s disease and other forms of dementia, scientists say this study is unlikely to be the last word on the topic. Indeed, it may just fuel an already lively debate over statins’ potential effect on dementia. Some research has hinted at benefits, while other studies, particularly in people with clear signs of Alzheimer’s disease, show no effect from the drugs [Science News].

The day after the
The American Academy of Pediatrics has issued new guidelines that call for testing at-risk children’s 